CoChat

Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studies

Hoffmann, Stefan A., Müller‐Vieira, Ursula, Biemel, Klaus, Knobeloch, Daniel, Heydel, Sandra, Lübberstedt, Marc, Nüssler, Andreas K., Andersson, Tommy B., Gerlach, Jörg C., Zeilinger, Katrin · 2012 · Biotechnology and Bioengineering
Cited by 69

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Based on a hollow fiber perfusion technology with internal oxygenation, a miniaturized bioreactor with a volume of 0.5 mL for in vitro studies was recently developed. Here, the suitability of this novel culture system for pharmacological studies was investigated, focusing on the model drug diclofenac. Primary human liver cells were cultivated in bioreactors and in conventional monolayer cultures in parallel over 10 days. From day 3 on, diclofenac was continuously applied at a therapeutic concentration (6.4 µM) for analysis of its metabolism. In addition, the activity and gene expression of the cytochrome P450 (CYP) isoforms CYP1A2, CYP2B6, CYP2C9, CYP2D6, and CYP3A4 were assessed. Diclofenac was metabolized in bioreactor cultures with an initial conversion rate of 230 ± 57 pmol/h/10 6 cells followed by a period of stable conversion of about 100 pmol/h/10 6 cells. All CYP activities tested were maintained until day 10 of bioreactor culture. The expression of corresponding mRNAs correlated well with the degree of preservation. Immunohistochemical characterization showed the formation of neo‐tissue with expression of CYP2C9 and CYP3A4 and the drug transporters breast cancer resistance protein (BCRP) and multidrug resistance protein 2 (MRP2) in the bioreactor. In contrast, monolayer cultures showed a rapid decline of diclofenac conversion and cells had largely lost activity and mRNA expression of the assessed CYP isoforms at the end of the culture period. In conclusion, diclofenac metabolism, CYP activities and gene expression levels were considerably more stable in bioreactor cultures, making the novel bioreactor a useful tool for pharmacological or toxicological investigations requiring a highly physiological in vitro representation of the liver. Biotechnol. Bioeng. 2012; 109: 3172–3181. © 2012 Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/bit.24573

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 69

Metadata

Authors
Hoffmann, S. A., Müller‐Vieira, U., Biemel, K., Knobeloch, D., Heydel, S., Lübberstedt, M., Nüssler, A. K., Andersson, T. B., Gerlach, J. C., & Zeilinger, K.
Venue
Biotechnology and Bioengineering
Publisher
Wiley
Published
2012-06-27
Volume
109
Issue
12
Pages
3172-3181
ISSN
  • 0006-3592 (ISSN-L)
  • 1097-0290
OpenAlex
W2067959462
Cited by
69
References
1
FWCI
5.24
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studies. https://app.cochat.ai/papers/10.1002/bit.24573
The paper
Hoffmann, S. A., Müller‐Vieira, U., Biemel, K., Knobeloch, D., Heydel, S., Lübberstedt, M., Nüssler, A. K., Andersson, T. B., Gerlach, J. C., & Zeilinger, K. (2012). Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studies. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.24573

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.